Filtros de búsqueda

Lista de obras de Martha Q Lacy

"IM iD"eally treating multiple myeloma

artículo científico publicado en 2013

59-year-old man with pelvic pain and hypergammaglobulinemia

artículo científico publicado en 2001

6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance

artículo científico publicado en 2006

6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis

scientific article published on 01 January 2007

A 66-year-old woman with an enlarged tongue.

artículo científico publicado en 2013

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published on June 2010

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

artículo científico publicado en 2013

A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.

artículo científico publicado en 2001

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

artículo científico publicado en 2002

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

artículo científico publicado en 2008

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma

artículo científico publicado en 2017

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

artículo científico publicado en 2005

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

artículo científico publicado en 2012

A phase II trial of imatinib in patients with refractory/relapsed myeloma

artículo científico publicado en 2006

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

artículo científico publicado en 2012

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

artículo científico publicado en 2007

A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial

artículo científico publicado en 2013

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

scientific article published on 01 April 1997

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

artículo científico publicado en 2005

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

scientific article published on 14 April 2020

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.

artículo científico publicado en 2015

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma

scientific article published on 01 September 1999

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

artículo científico publicado en 2006

Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

artículo científico publicado en 2004

Acquired Fanconi's syndrome associated with monoclonal gammopathies

artículo científico publicado en 1999

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

artículo científico publicado en 2012

Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT

scientific article published on 13 October 2008

Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis

artículo científico publicado en 2011

Acute lung toxicity related to pomalidomide

artículo científico publicado en 2011

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation

artículo científico publicado en 2005

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

scientific article published on 01 June 2006

Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma

artículo científico publicado en 2002

Amyloidosis

artículo científico publicado en 2005

Amyloidosis.

artículo científico publicado en 1999

Amyloidosis: diagnosis and management

artículo científico publicado en 2005

Amyloidosis: recognition, confirmation, prognosis, and therapy

scientific article published on 01 May 1999

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma.

artículo científico publicado en 2018

Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma

artículo científico publicado en 2016

Arterial thrombosis complicates myeloma?

scientific article published on 01 July 2010

Assessment of the Need for a Hematology-Specific Fellowship Curriculum for Advanced Practice Providers Using a Needs-Based Survey

scientific article published on 21 May 2019

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

artículo científico publicado en 2010

Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy

scientific article published on 14 July 2008

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

scholarly article by M Hasib Sidiqi et al published March 2019 in Biology of Blood and Marrow Transplantation

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

artículo científico publicado en 2018

Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.

artículo científico publicado en 2006

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.

artículo científico publicado en 2008

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

artículo científico publicado en 2010

Autologous stem cell transplant for multiple myeloma patients 70 years or older

artículo científico publicado en 2016

Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative

artículo científico publicado en 2008

Autologous stem cell transplantation and IgM amyloidosis

artículo científico publicado en 2006

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

artículo científico publicado en 2020

Autologous stem cell transplantation for relapsed and primary refractory myeloma

artículo científico publicado en 1999

Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency

artículo científico publicado en 2015

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.

artículo científico publicado en 2008

Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function

scientific article published on 08 April 2019

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

artículo científico publicado en 2016

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma

artículo científico publicado en 1999

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

artículo científico publicado en 2020

Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)

scientific article published on 01 November 2000

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis

scientific article published on 01 July 2002

Bone marrow angiogenesis in multiple myeloma: effect of therapy

article

Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist

artículo científico

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

scholarly article by M Hasib Sidiqi et al published 8 November 2018 in Blood Cancer Journal

CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia

artículo científico publicado en 2001

CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia

artículo científico publicado en 2001

CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies

artículo científico publicado en 2010

Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis

artículo científico publicado en 2016

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

artículo científico publicado en 2011

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

artículo científico publicado en 2017

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma.

artículo científico publicado en 2015

Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2020

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

artículo científico publicado en 2019

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation

scientific article published on 01 November 2001

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

artículo científico publicado en 2003

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

artículo científico publicado en 2002

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

artículo científico publicado en 2005

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

artículo científico publicado en 2010

Clinical Course and Prognosis of Non-Secretory Multiple Myeloma.

artículo científico publicado en 2015

Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.

artículo científico publicado en 2016

Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.

artículo científico publicado en 2015

Clinical characteristics and outcomes in biclonal gammopathies

artículo científico publicado en 2016

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

artículo científico publicado en 2020

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy.

artículo científico publicado en 2016

Clinical course and prognosis of non-secretory multiple myeloma

artículo científico publicado en 2015

Clinical course of patients with relapsed multiple myeloma

artículo científico publicado en 2004

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma ⬇️

artículo científico publicado en 2010

Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney

artículo científico publicado en 2011

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis

scientific article published on 05 March 2019

Clinical implication of centrosome amplification in plasma cell neoplasm

artículo científico publicado en 2005

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

artículo científico publicado en 2005

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

artículo científico publicado en 2009

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

artículo científico publicado en 2017

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

artículo científico publicado en 2017

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma

artículo científico publicado en 1999

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

scientific article published on 17 February 2017

Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies

scientific article published on 13 March 2012

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

artículo científico publicado en 2013

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

artículo científico publicado en 2005

Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial

artículo científico publicado en 2005

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

artículo científico publicado en 2002

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation

artículo científico publicado en 2008

Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.

artículo científico publicado en 2018

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

artículo científico publicado en 2008

Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma

artículo científico publicado en 1999

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

artículo científico publicado en 2010

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

artículo científico publicado en 2013

Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma

scientific article published on 01 April 1998

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

artículo científico publicado en 2020

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

artículo científico publicado en 2020

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization

artículo científico publicado en 2012

Current status of stem cell transplantation for multiple myeloma

artículo científico publicado en 2005

Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma

artículo científico publicado en 2006

Cytogenetic Abnormalities Correlate with the Plasma Cell Labeling Index and Extent of Bone Marrow Involvement in Myeloma

article

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

artículo científico publicado en 2019

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

artículo científico publicado en 2020

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

artículo científico publicado en 2018

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

scientific article published on 21 October 2019

Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma

artículo científico publicado en 2000

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression

article

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

artículo científico

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.

artículo científico publicado en 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis

artículo científico publicado en 2020

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

artículo científico publicado en 2019

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

artículo científico

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

artículo científico publicado en 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

artículo científico publicado en 2010

Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

artículo científico publicado en 2020

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

article by Eli Muchtar et al published 12 March 2018 in Amyloid

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

artículo científico publicado en 2010

Discordant distribution of JAK2V617F mutation in siblings with familial myeloproliferative disorders

artículo científico publicado en 2006

Disseminated nocardiosis after allogeneic bone marrow transplantation ⬇️

artículo científico publicado el 1 de septiembre de 1997

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma

artículo científico publicado en 1999

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis

artículo científico publicado en 2005

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

artículo científico publicado en 2001

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

artículo científico publicado en 2016

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

artículo científico publicado en 2011

Effect of complete response on outcome following autologous stem cell transplantation for myeloma

scientific article published on 01 November 2000

Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response

artículo científico publicado en 2007

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia

artículo científico publicado en 2001

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

artículo científico publicado en 2003

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

artículo científico publicado en 2004

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

artículo científico publicado en 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

artículo científico publicado en 2017

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

artículo científico publicado en 2011

Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma

artículo científico publicado en 2011

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation

artículo científico publicado en 2017

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

artículo científico publicado en 2017

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

artículo científico publicado en 2001

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

artículo científico publicado en 2020

Erratum: Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT

scholarly article published in Bone Marrow Transplantation

Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis

scholarly article published in Leukemia

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

scientific article published on 13 July 2012

Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie

artículo científico publicado en 2010

Evidence of Impaired Left Ventricular Systolic Function by Doppler Myocardial Imaging in Patients With Systemic Amyloidosis and No Evidence of Cardiac Involvement by Standard Two-Dimensional and Doppler Echocardiography

article

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

artículo científico publicado en 2016

Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients.

artículo científico publicado en 2005

Expression of mRNA for a newly identified Pax5 exon is reduced in multiple myeloma

artículo científico publicado en 2006

Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

scientific article published on 09 August 2007

Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

artículo científico publicado en 2009

Factors influencing platelet recovery after blood cell transplantation in multiple myeloma ⬇️

artículo científico publicado el 1 de septiembre de 1997

Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: a report and review of growth factor-induced pulmonary toxicity

artículo científico publicado en 2000

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

scientific article published on 11 July 2019

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.

artículo científico publicado en 2016

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.

artículo científico publicado en 2006

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system

artículo científico publicado en 2005

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

artículo científico publicado en 2006

Genetic aberrations and survival in plasma cell leukemia

artículo científico publicado en 2008

Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits

artículo científico

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

artículo científico publicado en 2017

Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma

scientific article published on 29 September 2011

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

scientific article published on 29 October 2019

High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis

artículo científico publicado en 2001

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis

scientific article published on 08 January 2014

High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma

artículo científico publicado en 2006

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

artículo científico publicado en 2011

High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy

artículo científico publicado en 2004

Holistic Review for Hematology-Oncology Fellowship Applicants: A New Paradigm?

artículo científico publicado en 2020

IAP antagonists induce anti-tumor immunity in multiple myeloma.

artículo científico publicado en 2016

IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma

artículo científico publicado en 2002

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

artículo científico publicado en 2014

Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.

artículo científico publicado en 2006

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

artículo científico publicado en 2009

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

scientific article published on 28 November 2019

Immunoglobulin D amyloidosis: a distinct entity

artículo científico publicado en 2011

Immunoglobulin light chain amyloidosis and the kidney

artículo científico publicado en 2002

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias

scientific article published on 02 September 2014

Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation

artículo científico publicado en 2001

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

artículo científico publicado en 2016

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

artículo científico publicado en 2016

Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods

artículo científico publicado en 2017

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics.

artículo científico publicado en 2017

Impact of acquired del(17p) in multiple myeloma

artículo científico publicado en 2019

Impact of additional cytoreduction following autologous SCT in multiple myeloma.

scientific article published on 16 June 2008

Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma

scientific article published on 19 March 2007

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

scientific article published on 23 July 2019

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

artículo científico publicado en 2015

Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2009

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

artículo científico publicado en 2018

Impact of early relapse after auto-SCT for multiple myeloma.

artículo científico publicado en 2008

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

artículo científico publicado en 2017

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

artículo científico publicado en 2007

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

artículo científico publicado en 2020

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.

artículo científico publicado en 2016

Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.

artículo científico publicado en 2008

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

artículo científico publicado en 2017

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

artículo científico publicado en 2009

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

artículo científico publicado en 2020

Implications of continued response after autologous stem cell transplantation for multiple myeloma

artículo científico publicado en 2013

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

artículo científico publicado en 2020

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

artículo científico publicado en 2013

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

artículo científico publicado en 2017

Improved survival in multiple myeloma and the impact of novel therapies

artículo científico publicado en 2007

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2015

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

artículo científico publicado en 2008

In vivo and in silico studies on single versus multiple transplants for multiple myeloma.

artículo científico publicado en 2007

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

artículo científico publicado en 2011

Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation

artículo científico publicado en 2013

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

scientific article published on 07 April 2020

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

artículo científico publicado en 2018

Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study

artículo científico publicado en 2010

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

artículo científico publicado en 2009

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

artículo científico publicado en 2016

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

artículo científico publicado en 2016

Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors

scientific article published on 01 February 2017

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders

scientific article published on 30 May 2018

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

artículo científico publicado en 2015

Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation

scientific article published on 01 March 1998

Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques

artículo científico publicado en 2004

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

artículo científico publicado en 2009

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

artículo científico publicado en 2011

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

artículo científico publicado en 2012

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

artículo científico publicado en 2018

Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.

artículo científico publicado en 2005

Localized AL amyloidosis of the colon: an unrecognized entity

artículo científico publicado en 2003

Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience

artículo científico publicado en 2016

Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation.

artículo científico publicado en 2015

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy

artículo científico publicado en 2014

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.

artículo científico publicado en 2008

Long-term outcome of autologous stem cell transplantation in light chain deposition disease

artículo científico publicado en 2008

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

artículo científico publicado en 2016

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

artículo científico publicado en 2013

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

artículo científico publicado en 2013

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

artículo científico publicado en 2012

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

artículo científico publicado en 2020

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation

artículo científico publicado en 2011

Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma.

artículo científico publicado en 2013

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

artículo científico publicado en 2007

Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

artículo científico publicado en 2010

Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia

artículo científico publicado en 2014

Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis

artículo científico publicado en 2008

Long-term survival (10 years or more) in 30 patients with primary amyloidosis

scientific article published on 01 February 1999

Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms.

artículo científico publicado en 2013

Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization

artículo científico publicado en 2010

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia

artículo científico publicado en 2003

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

artículo científico publicado en 2017

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

artículo científico publicado en 2011

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

artículo científico

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

artículo científico publicado en 2006

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis

artículo científico publicado en 2011

Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma

artículo científico publicado en 2020

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

artículo científico publicado en 2020

Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation

article

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

article

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

artículo científico publicado en 2007

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

artículo científico publicado en 2019

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

Multiple myeloma after kidney transplantation

artículo científico publicado en 2014

Multiple myeloma associated with diffuse osteosclerotic bone lesions: A clinical entity distinct from osteosclerotic myeloma (POEMS syndrome) ⬇️

artículo científico publicado el 1 de diciembre de 1997

Multiple myeloma: new options, new challenges

scientific article published on 01 July 2006

Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement

artículo científico publicado en 2005

Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report

artículo científico publicado en 2000

Myelomatous Involvement of the Central Nervous System

artículo científico publicado en 2016

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2016

Natural history of amyloidosis isolated to fat and bone marrow aspirate.

artículo científico publicado en 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Natural history of t(11;14) multiple myeloma

artículo científico publicado en 2017

Natural history of thromboembolism in AL amyloidosis

artículo científico publicado en 2006

New immunomodulatory drugs in myeloma

artículo científico publicado en 2011

Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma

artículo científico publicado en 2007

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma

artículo científico publicado en 2016

Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease

artículo científico publicado en 2002

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

scientific article published on 22 June 2019

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

artículo científico publicado en 2008

Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.

artículo científico publicado en 2014

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

artículo científico publicado en 2019

Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation

artículo científico

Outcomes of patients with POEMS syndrome treated initially with radiation

artículo científico publicado en 2013

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

artículo científico publicado en 2016

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

artículo científico publicado en 2015

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma

scientific article published on 16 December 2020

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2019

Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis

artículo científico publicado en 2020

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

artículo científico publicado en 2017

PET Imaging of a Unique Case of Multiple Myeloma in an Adolescent

scientific article published on 17 July 2020

POEMS syndrome: definitions and long-term outcome

artículo científico publicado en 2002

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center

artículo científico publicado en 2013

Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation

artículo científico publicado en 2001

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

artículo científico publicado en 2008

Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature

artículo científico publicado en 2004

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

artículo científico publicado en 2013

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

artículo científico publicado en 2015

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

artículo científico publicado en 2010

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

artículo científico publicado en 2017

Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma

artículo científico publicado en 2008

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

artículo científico publicado en 2015

Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group

artículo científico publicado en 2009

Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.

artículo científico publicado en 1999

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis

artículo científico publicado en 1999

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia

artículo científico publicado en 2010

Pitfalls in the diagnosis of primary amyloidosis

artículo científico publicado en 2010

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

artículo científico publicado en 2018

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation.

artículo científico publicado en 2018

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma

artículo científico publicado en 1999

Ploidy status rarely changes in myeloma patients at disease progression.

artículo científico publicado en 2005

Pomalidomide

artículo científico

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

artículo científico publicado en 2010

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

artículo científico publicado en 2009

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study

artículo científico publicado en 2014

Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologist

artículo científico publicado en 2013

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

artículo científico publicado en 2011

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

artículo científico publicado en 2013

Pomalidomide therapy for multiple myeloma and myelofibrosis: an update

artículo científico publicado en 2011

Pomalidomide – An Appraisal of Its Clinical Development and Role in the Treatment of Relapsed/Refractory Multiple Myeloma

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

artículo científico publicado en 2017

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

artículo científico

Pomalidomide: a new IMiD with remarkable activity in both multiple myeloma and myelofibrosis

artículo científico publicado en 2010

Pomalidomide: new immunomodulatory agent with potent antiproliferative effects

artículo científico

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma.

artículo científico

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis

artículo científico publicado en 2003

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.

artículo científico publicado en 2015

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

artículo científico publicado en 2003

Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.

artículo científico publicado en 2010

Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification.

artículo científico publicado en 2013

Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study

artículo científico publicado en 2008

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

artículo científico publicado en 2015

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

artículo científico publicado en 2017

Predictors of short-term survival in Waldenström Macroglobulinemia

artículo científico publicado en 2020

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

scientific article published on 02 October 2018

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

artículo científico publicado en 2017

Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

artículo científico publicado en 2017

Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy

artículo científico publicado en 2006

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Primary systemic amyloidosis: a cause of malabsorption syndrome

artículo científico publicado en 2001

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

scientific article published on 02 February 2019

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis

artículo científico publicado en 2018

Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance

article

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.

artículo científico publicado en 2006

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

artículo científico publicado en 2017

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

artículo científico publicado en 2006

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

artículo científico publicado en 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis.

artículo científico publicado en 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

artículo científico publicado en 2020

Prognostic value of angiogenesis in solitary bone plasmacytoma

artículo científico publicado en 2002

Prognostic value of bone marrow angiogenesis in multiple myeloma

artículo científico publicado en 2000

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.

artículo científico publicado en 2004

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

artículo científico publicado en 2006

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

artículo científico publicado en 2019

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

artículo científico publicado en 2004

Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease

artículo científico publicado en 2001

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis

artículo científico publicado en 1999

Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis

artículo científico publicado en 2001

Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities.

artículo científico publicado en 1996

Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

artículo científico publicado en 2016

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

artículo científico publicado en 2014

Quantification of clonal circulating plasma cells in relapsed multiple myeloma

artículo científico publicado en 2014

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

artículo científico publicado en 2016

Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

scientific article published on 29 July 2016

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method

scientific article published on 08 January 2019

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

artículo científico publicado en 2011

Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma

artículo científico

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

artículo científico publicado en 2012

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

artículo científico publicado en 2020

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

artículo científico publicado en 2018

Relationship Between Depth of Response and Outcome in Multiple Myeloma

scientific article published on 01 November 2007

Remission of disseminated cancer after systemic oncolytic virotherapy

artículo científico publicado en 2014

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis

artículo científico publicado en 2005

Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myeloma

artículo científico publicado en 2010

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

artículo científico publicado en 2003

Response to rituximab in patients with type II cryoglobulinemia

artículo científico publicado en 2006

Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy

artículo científico publicado en 2011

Response: pure red blood cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities

artículo científico publicado en 1996

Retroperitoneal involvement with light chain amyloidosis- case series and literature review

artículo científico publicado en 2020

Review of 1027 patients with newly diagnosed multiple myeloma

artículo científico publicado en 2003

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

scholarly article by Praful Ravi et al published 15 November 2018 in Blood Cancer Journal

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

artículo científico publicado en 2012

Revisiting complete response in light chain amyloidosis

scientific article published on 26 November 2019

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.

artículo científico publicado en 2017

Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

artículo científico publicado en 2015

Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.

artículo científico publicado en 2016

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

artículo científico publicado en 2018

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

artículo científico publicado en 2004

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization

artículo científico publicado en 2010

Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

artículo científico publicado en 2018

Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS.

artículo científico publicado en 2016

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation

artículo científico publicado en 2018

Salvage autologous stem cell transplant is an effective regimen for relapsed multiple myeloma.

artículo científico publicado en 2013

Second auto-SCT for treatment of relapsed multiple myeloma

artículo científico publicado en 2012

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

artículo científico publicado en 2003

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation

artículo científico publicado en 2017

Serum M-spike and transplant outcome in patients with multiple myeloma.

artículo científico publicado en 2007

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

artículo científico publicado en 2004

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome

artículo científico publicado en 2010

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

artículo científico publicado en 2010

Serum uric acid: novel prognostic factor in primary systemic amyloidosis

artículo científico publicado en 2008

Severe reversible pulmonary hypertension in smoldering multiple myeloma: two cases and review of the literature

artículo científico publicado en 2015

Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis

artículo científico publicado en 2004

Severity of Baseline Proteinuria Predicts Renal Response in Immunoglobulin Light Chain-Associated Amyloidosis after Autologous Stem Cell Transplantation

artículo científico publicado en 2007

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

artículo científico publicado en 2004

Smoldering multiple myeloma requiring treatment: time for a new definition?

artículo científico publicado en 2013

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

artículo científico publicado en 2015

Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time.

artículo científico publicado en 2018

Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis

artículo científico publicado en 2016

Stem cell transplantation for the management of primary systemic amyloidosis

artículo científico publicado en 2002

Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction

artículo científico publicado en 2010

Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis

artículo científico publicado en 2010

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation

artículo científico publicado en 2001

Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation

artículo científico publicado en 2005

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

artículo científico publicado en 2004

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

artículo científico publicado en 2016

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2013

Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis

artículo científico publicado en 2012

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

Thalidomide as initial therapy for early-stage myeloma

artículo científico publicado en 2003

Thalidomide for previously untreated indolent or smoldering multiple myeloma

artículo científico publicado en 2001

Thalidomide in the treatment of relapsed multiple myeloma

scientific article published on 01 September 2000

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

artículo científico publicado en 2006

The clinical significance of cereblon expression in multiple myeloma

artículo científico publicado en 2013

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

artículo científico publicado en 2004

The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma

artículo científico publicado en 2005

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

artículo científico publicado en 2015

The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents.

artículo científico publicado en 2016

The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma

artículo científico publicado en 2019

The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2016

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

artículo científico publicado en 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

artículo científico publicado en 2016

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome

scientific article published on 31 August 2011

The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group.

artículo científico publicado en 2005

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

artículo científico publicado en 2017

Therapy for immunoglobulin light chain amyloidosis: the new and the old.

artículo científico publicado en 2004

Thromboembolic events with lenalidomide-based therapy for multiple myeloma

artículo científico publicado en 2008

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

artículo científico publicado en 2018

Transition of Care for Inpatient Hematology Patients Receiving Chemotherapy: Development of Hospital Discharge Huddle Process and Effects of Implementation

artículo científico publicado en 2015

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

artículo científico publicado en 2009

Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis

artículo científico publicado en 2001

Transplantation for amyloidosis

artículo científico publicado en 2007

Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).

artículo científico publicado en 2007

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

scientific article published on 15 October 2020

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

artículo científico

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

artículo científico publicado en 2019

Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis

artículo científico publicado en 2007

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

artículo científico publicado en 2007

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

article

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

artículo científico publicado en 2017

Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006.

artículo científico publicado en 2011

Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic

artículo científico

Trends and outcomes of modern staging of solitary plasmacytoma of bone

artículo científico publicado en 2012

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.

artículo científico publicado en 2010

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

artículo científico publicado en 2014

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

artículo científico publicado en 2012

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.

artículo científico publicado en 2008

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

artículo científico publicado en 2006

Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases

artículo científico publicado en 2012

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

artículo científico publicado en 2020

Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma

artículo científico publicado en 2020

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2018

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

artículo científico publicado en 2020

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

artículo científico publicado en 2015

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

artículo científico publicado en 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

artículo científico publicado en 2019

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

artículo científico publicado en 2020

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator

artículo científico publicado en 2002

Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil

artículo científico publicado en 2000

c-erbB-2 and p53 expression in fallopian tube carcinoma

artículo científico publicado en 1995

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda